Profil
Kelley Kendle is currently the Chief Executive Officer at UserWise LLC, as well as the Chairman and Chief Executive Officer at ClariMed, Inc. and the Director at Framework Solutions, Inc. In the past, Ms. Kendle worked as the President-Regulatory Strategy, Sciences & Services at Synchrogenix Information Strategies LLC (New Jersey).
Postes actifs de Kelley Kendle
| Sociétés | Poste | Début |
|---|---|---|
Framework Solutions, Inc.
Framework Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical to commercial solutions to biotechnology, pharmaceutical and medical device companies | Directeur/Membre du Conseil | 03/05/2022 |
UserWise LLC
UserWise LLC Medical SpecialtiesHealth Technology Manufactures medical equipment | Directeur Général | 01/08/2022 |
ClariMed, Inc.
ClariMed, Inc. Medical SpecialtiesHealth Technology Develops medical devices | Directeur Général | - |
Anciens postes connus de Kelley Kendle
| Sociétés | Poste | Fin |
|---|---|---|
Synchrogenix Information Strategies LLC (New Jersey)
Synchrogenix Information Strategies LLC (New Jersey) Miscellaneous Commercial ServicesCommercial Services Provides regulatory writing services | Directeur Général | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Synchrogenix Information Strategies LLC (New Jersey)
Synchrogenix Information Strategies LLC (New Jersey) Miscellaneous Commercial ServicesCommercial Services Provides regulatory writing services | Commercial Services |
Framework Solutions, Inc.
Framework Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical to commercial solutions to biotechnology, pharmaceutical and medical device companies | Commercial Services |
UserWise LLC
UserWise LLC Medical SpecialtiesHealth Technology Manufactures medical equipment | Health Technology |
ClariMed, Inc.
ClariMed, Inc. Medical SpecialtiesHealth Technology Develops medical devices | Health Technology |
















